Early Detection Matters: Insights into Alzheimer’s Treatments and Caregiving

In this episode of Conversations That Matter we’re talking about the latest in Alzheimer’s progress in diagnosis and treatments, support for families and how we tackle stigma head on. We’re joined by two outstanding guests. Muffy Walker is a psychiatric nurse, longtime mental health advocate, founder of the International Bipolar Foundation and author of Memory … Read more

Coya Therapeutics moves from IND clearance to Phase 2 in ALS research

In this episode of Conversations That Matters, Dr. Fred Grossman, President and Chief Medical Officer of Coya Therapeutics, a clinical stage biotech company developing therapies intended to enhance regulatory T-cell functions to target systemic inflammation and neuroinflammation, joins Solomon Wilcots in discussing new clinical developments the company has made. Today, he is here to share … Read more